Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (27)
  • 2024 (35)
  • 2023 (46)
  • 2022 (71)
  • 2021 (79)
  • 2020 (37)
  • 2019 (71)
  • 2018 (42)

Subject

  • Drug Trafficking (29)
  • Synthetic drugs (23)
  • Prescription Drugs (22)
  • Pharmaceuticals/Pharmacists/Physicians (20)
  • Seizures (Drugs/Property) (16)
  • Diversion Division (14)
  • Task Forces/Task Force Officers (13)
  • Arrests/Convictions - Major (11)
  • Overdose (11)
  • Major Law Enforcement Operation (10)
  • OCDETF/Task Force (7)
  • Outreach/Drug Prevention (7)
  • Guilty Plea (6)
  • Guns/Weapons (6)
  • Dark Web- Internet Trafficking (5)
  • Fake Pills (4)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Gangs (3)
  • Asset Forfeiture (2)
  • Narcoterrorism (2)
  • Press Conferences (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Intelligence Division - Intelligence Products (1)
  • Money Laundering (1)
  • Take Back Day (1)

Drug Name

  • Fentanyl (267)
  • Methamphetamine (256)
  • Cocaine (246)
  • Heroin (151)
  • Marijuana (Cannabis) (52)
  • Opioids (52)
  • Benzodiazepines (9)
  • Amphetamines (8)
  • Ecstasy/MDMA (5)
  • Morphine (5)
  • Hydromorphone (4)
  • K2/Spice (3)
  • Methadone (3)
  • Ketamine (2)
  • Steroids (2)
  • LSD (1)
  • Marijuana Concentrates (1)
  • Oxycodone (58)
  • Synthetic Opioids (28)

Field Division

  • Washington, DC (26)
  • Atlanta (20)
  • New York (5)
  • Seattle (5)
  • St. Louis (5)
  • Chicago (3)
  • Headquarters (3)
  • Houston (3)
  • Miami (3)
  • New Jersey (2)
  • Dallas (1)
  • New England (1)
  • New Orleans (1)
  • Omaha (1)
Clear All Results
PRESS RELEASE

Operators of Three Texas Pharmacies and Two Pain Clinics Arrested for Illegally Dispensing Nearly Four Million Opioid Pills

December 21, 2021
WASHINGTON – Three Houston-area pharmacists, a doctor, and a pharmacy technician have been arrested for allegedly running three pharmacies and two clinics as “pill mills;” distributing hydrocodone, oxycodone, and other controlled drugs without a legitimate medical purpose. According to court documents, since January 2018, Chrisco Pharmacy (Chrisco), Keystone Pharmacy (Keystone)...
December 21, 2021
PRESS RELEASE

Former Long Island Doctor Sentenced to 23 Years in Prison for Causing the Overdose Deaths of Two patients and Illegally Distributing Oxycodone

December 16, 2021
CENTRAL ISLIP, N.Y. - Earlier today, in federal court in Central Islip, Michael Belfiore, a former medical doctor, was sentenced by United States Circuit Judge Joseph F. Bianco to 23 years in prison for the illegal distribution of oxycodone causing the deaths of two patients and the illegal distribution of...
December 16, 2021
PRESS RELEASE

Naples Doctor Who Operated a Pill Mill Sentenced to Three Years in Federal Prison

December 06, 2021
FORT MYERS, Fla. – U.S. District Judge Sheri Polster Chappell today sentenced Gerald Michael Abraham, 76, of Naples, Florida. to three years in federal prison for dispensing controlled substances (oxycodone and amphetamine) for no legitimate medical purpose. The court also ordered Abraham to forfeit the following items to the United...
December 06, 2021
PRESS RELEASE

Savannah Woman Pleads Guilty to Laundering ‘Pill Mill’ Money

December 06, 2021
SAVANNAH, Ga. -- A former Garden City, Ga., clinic owner and CEO has admitted to laundering money in connection with a notorious “pill mill” doctor who illegally dispensed massive amounts of controlled substances. Jamesetta Whipple-Duncan, 58, of Savannah, pled guilty in U.S. District Court to one count of money laundering...
December 06, 2021
PRESS RELEASE

Virtua Health Inc. to Pay $150,000 to Settle Controlled Substances Act Allegations

December 03, 2021
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and Acting U.S. Attorney for the District of New Jersey Rachael A. Honig announced a nonprofit healthcare system that owns and operates a network of healthcare entities has agreed to pay $150,000...
December 03, 2021
PRESS RELEASE

Member of Southwest Baltimore “NFL” Gang Pleads Guilty to a Federal Racketeering, Distributing Large Quantities of Drugs, Two Murders and an Attempted Murder

December 03, 2021
Greenbelt, Md., – Bobby Cannon, a/k/a Freaky, age 24 of Baltimore, pleaded guilty today to participating in a violent racketeering conspiracy, specifically, the NFL Criminal Enterprise, including committing two murders. The term "NFL" stands for Normandy, Franklin, and Loudon, which are three adjacent streets that run through the Edmondson Village...
December 03, 2021
PRESS RELEASE

Hanover Man Pleads Guilty to Distribution of Fentanyl, Cocaine, and Other Drugs Shipped Through the Mail from California to Maryland

November 22, 2021
Baltimore, Md., – Dwight Antonio Pitts, age 47, of Hanover, Maryland, pleaded guilty on November 19, 2021, to charges related to his participation in a drug distribution conspiracy involving large amounts of fentanyl, cocaine, and other drugs, shipped through the U.S. Mail from California to Maryland. The guilty plea was...
November 22, 2021
PRESS RELEASE

Federal Consent Decree Permanently Bans Baltimore-Based Physician Assistant from Prescribing Opioids and Controlled Substances

November 19, 2021
Baltimore, Md., – U.S. District Judge Deborah L. Boardman has approved a consent decree that permanently enjoins Elizabeth J. Allen, a Baltimore-based physician assistant, from prescribing opioids and other controlled substances, resolving the United States’ civil allegations that Allen violated the Controlled Substances Act (CSA) in illegally prescribing opioids. Under...
November 19, 2021
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

November 17, 2021
Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
November 17, 2021
PRESS RELEASE

Pharmacist Found Guilty of Illegally Dispensing and Distributing Controlled Substances

November 10, 2021
ATLANTA - Thomas Ukoshovbera A. Gbenedio has been convicted by a federal jury of illegally dispensing and distributing controlled substances from his pharmacy. “Removing and ultimately eliminating healthcare providers who unlawfully dispense pharmaceutical products for non-medical reasons is an important part of DEA’s mission,” said Special Agent in Charge of...
November 10, 2021
Showing 1 - 10 of 79 results

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster